Lorazepam
NDC Package 52959-331-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lorazepam is a medication used to treat anxiety. Marketed by H.j. Harkins Company, Inc., this product is identified by NDC 52959-331 and is authorized under FDA application ANDA071404.

Identification & Billing

NDC Package Code
52959-331-40
Package Description
40 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
52959033140
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
40 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lorazepam
Dosage Form
-
Usage Information
This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

Regulatory & Marketing

Labeler Name
H.j. Harkins Company, Inc.
FDA Application #
ANDA071404
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-12-1996
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (52959-331). Click a package code to view its specific billing and regulatory data.

100 TABLET in 1 BOTTLE
1 TABLET in 1 BOTTLE
2 TABLET in 1 BOTTLE
7 TABLET in 1 BOTTLE
15 TABLET in 1 BOTTLE
20 TABLET in 1 BOTTLE
30 TABLET in 1 BOTTLE
60 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52959-331-40 identifies a specific commercial package of 40 tablet in 1 bottle of Lorazepam, labeled by H.j. Harkins Company, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 40 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by H.j. Harkins Company, Inc. on February 12, 1996. The current certification is valid through December 31, 2019.

What are the primary indications for this medication?

This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this H.j. Harkins Company, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52959033140. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 40 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52959-331-40
11-Digit CMS (5-4-2)
52959-0331-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.